Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone

Journal of Virology

Volumn 75, Issue 11, 2001, Pages 4964-4972

  Ndung'u, Thumbi ^a   Renjifo, Boris ^a   Essex, Max ^a  

^a Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CHIMERA; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GENE CONSTRUCT; GENE REPLICATION; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOLECULAR CLONING; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AFRICA; AMINO ACID SEQUENCE; ASIA; CELLS, CULTURED; CLONING, MOLECULAR; GENOME, VIRAL; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECEPTORS, CCR5; SEQUENCE ALIGNMENT; TRANSFECTION; VIRUS REPLICATION;

EID: 0035026761     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.11.4964-4972.2001     Document Type: Article

References (54)

1. Asjo, B., L. Morfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and E. M. Fenyo. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-662.
2. Berkowitz, R. D., S. Alexander, C. Bare, V. Linquist-Stepps, M. Bogan, M. E. Moreno, L. Gibson, E. D. Wieder, J. Kosek, C. A. Stoddart, and J. M. McCune. 1998. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J. Virol. 72:10108-10117.
3. Berkowitz, R. D., A. B. Van't Wout, N. A. Kootstra, M. E. Moreno, V. D. Linquist-Stepps, C. Bare. C. A. Stoddart, H. Schuitemaker, and J. M. McCune. 1999. R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. J. Virol. 73:7817-7822.
4. Bjorndal, A., A. Sonnerborg, C. Tscherning, J. Albert, and E. Fenyo. 1999. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retrovir. 15:647-653.
5. Blackard, J. T., B. R. Renjifo, D. Mwakagile, M. A. Montano, W. W. Fawzi, and M. Essex. 1999. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology 254:220-225.
6. Brookmeyer, R., S. M. Mehendale, R. K. Pelz, M. E. Shepherd, T. Quinn, J. J. Rodrigues, and R. C. Bollinger. 1996. Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. AIDS 10:924-925.
7. Cecilia, D., S. S. Kulkarni, S. P. Tripathy, R. R. Gangakhedkar, R. S. Paranjape, and D. A. Gadkari. 2000. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 271:253-258.
8. Chen, Z., Y. Huang, X. Zhao, E. Skulsky, D. Lin, J. Ip, A. Gettie, and D. D. Ho. 2000. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J. Virol. 74:6501-6510.
9. Dedera, D., R. Gu, and L. Ratner. 1992. Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage. J. Virol. 66:1207-1209.
10. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
11. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
12. Essex, M. 1999. Human immunodeficiency viruses of the developing world. Adv. Virus Res. 53:71-88.
13. European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS. 1997. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines, and diagnostics. Workshop report. AIDS 11: 17-36.
14. Fenyo, E. M., L. Morfeldt-Manson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Asjo. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
15. Gao, F., D. Robertson, C. Carruthers, S. Morrison, B. Jian, Y. Chen, F. Barre-Sinoussi, M. Girard, A. Srinivasan, A. Abimiku, G. Shaw, P. Sharp, and B. Hahn. 1998. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J. Virol. 72:5680-5698.
16. Gartner, S., P. Markovits, D. M. Markovitz, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
17. Gurtler, L., P. Hauser, J. Erberle, A. von Brunn, S. Knapp, L. Zekeng, J. Tsague, and L. Kaplue. 1994. A new subtype of human immunodeficiency virus type 1 (MVP5180) from Cameroon. J. Virol. 68:1581-1585.
18. Harouse, J. M., A. Gettie, R. C. H. Tan, J. Blanchard, and C. Cheng-Mayer. 1999. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284:816-819.
19. Helseth, E., M. Kowalski, D. Gabuzda, U. Olshevsky, W. Haseltine, and J. Sodroski. 1990. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64:2416-2420.
20. Hu, D., T. Dondero, M. Rayfield, J. George, G. Schochetman, H. Jaffe, C. Luo, M. Kalish, B. Weniger, C. Pau, C. Sellable, and J. Curran. 1996. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 275:210-216.
21. Janssens, W., A. Buve, and J. N. Nkengasong. 1997. The puzzle of HIV-1 subtypes in Africa. AIDS 11:705-712.
22. Jeeninga, R., M. Hoogenkamp, M. Armand-Ugon, M. De Baar, K. Verhoef, and B. Berkhout. 2000. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74:3740-3751.
23. Kanki, P., D. Hamel, J. Sankale, C. Hsieh, I. Thior, F. Barin, S. Woodcock, A. Gueye-Ndiaye, E. Zhang, M. Montano, T. Siby, R. Marlink, I. NDoye, M. Essex, and S. MBoup. 1999. Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179:68-73.
24. Kuiken, C., B. Foley, B. Hahn, P. Marx, F. McCutchan, J. Mellors, J. Mullins, S. Wolinsky, and B. E. Korber. 1999. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
25. Lole, K., R. Bollinger, R. Paranjape, D. Gadkari, S. Kulkarni, N. Novak, R. Ingersoll, H. Sheppard, and S. Ray. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infecled seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160.
26. Mochizuki, N., N. Otsuka, K. Matsuo, T. Shiino, A. Kojima, T. Kurata, K. Sakai, N. Yamamoto, S. Isomura, T. Dhole, Y. Takebe, M. Matsuda, and M. Tatsumi. 1999. An infectious DNA clone of HIV type 1 subtype C. AIDS Res. Hum. Retrovir. 15:1321-1324.
27. Montano, M., C. Nixon, T. Ndung'u, H. Bussmann, V. Novitsky, D. Dickman, and M. Essex. 2000. Elevated tumor necrosis factor-α activation of human immunodeficiency virus type 1 subtype C in southern Africa is associated with an NF-κB enhancer gain-of-function. J. Infect. Dis. 181:76-81.
28. Montano, M., V. Novitsky, J. Blackard, N. Cho, D. Katzenstein, and M. Essex. 1997. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 71:8657-8665.
29. Myers, G., B. Korber, J. A. Berzofsky, R. F. Smith, and G. N. Pavlakis. 1997. Human retroviruses and AIDS. Theoretical Biology and Biophysics Group. Los Alamos National Laboratory, Los Alamos, N.Mex.
30. Naghavi, M., S. Schwartz, A. Sonnerborg, and A. Vahlne. 1999. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res. Hum. Retrovir. 15:1293-1303.
31. Ndung'u, T., B. Renjifo, V. A. Novitsky, M. F. McLane, S. Gaolekwe, and M. Essex. 2000. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology 278:390-399.
32. Neilson, J., G. John, J. Carr, P. Lewis, J. Kreiss, S. Jackson, R. Nduati, D. Mbori-Ngacha, D. Panteleeff, S. Bodrug, C. Giachetti, M. Bott, B. Richardson, J. Bwayo, J. Ndinya-Achola, and J. Overbaugh. 1999. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J. Virol. 73:4393-4403.
33. Novitsky, V., M. Montano, M. McLane, B. Renjifo, F. Vannberg, B. Foley, T. Ndung'u, M. Rahman, M. Makhema, R. Marlink, and M. Essex. 1999. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J. Virol. 73:4427-4432.
34. Novitsky, V. A., S. Gaolekwe, M. F. McLane, T. P. Ndung'u, B. T. Foley, F. Vannberg, R. Marlink, and M. Essex. 2000. HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. AIDS Res. Hum. Retrovir. 16:1015-1020.
35. Perriere, G., and M. Gouy. 1996. WWW-query: an on-line retrieval system for biological sequence banks. Biochimie 78:364-369.
36. Ping, L., J. Nelson, I. Hoffman, J. Schock, S. Lamers, M. Goodman, P. Vernazza, P. Kazembe, M. Maida, D. Zimba, M. Goodenow, J. Eron, Jr., S. Fiscus, M. Cohen, and R. Swanstrom. 1999. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J. Virol. 73:6271-6281.
37. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R. S. Liou, R. C. Gallo, and F. Wong-Staal. 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retrovir. 3:57-69.
38. Renjifo, B., W. Fawzi, D. Mwakagile, D. Hunter, G. Msamanga, M. Spiegelman, C. Garland, C. Kagoma, A. Kim, B. Chaplin, E. Hertzmark, and M. Essex. 2001. Differences in perinatal transmission between HIV-1 genotypes. J. Hum. Virol. 4:1-11.
39. Renjifo, B., P. Gilbert, B. Chaplin, F. Vannberg, D. Mwakagile, G. Msamanga, D. Hunter, W. Fawzi, and M. Essex. 1999. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. AIDS 13:1613-1621.
40. Rizzuto, C. D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
41. Robertson, D. L, J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn, M. L. Kalish, C. Kuiken, G. H. Learn, T. Leitner, F. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P. M. Sharp, S. Wolinsky, and B. Korber. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
42. Salminen, M. O., B. Johansson, A. Sonnerborg, S. Ayehunie, D. Gotte, P. Leinikki, D. S. Burke, and F. E. McCutchan. 1996. Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res. Hum. Retrovir. 12:1329-1339.
43. Simon, F., P. Mauclere, P. Roques, I. Loussert-Ajaka, M. Muller-Trutwin, S. Saragosti, M. Georges-Courbot, F. Barre-Sinoussi, and F. Brun-Vezinet. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and O. Nat. Med. 4:1032-1037.
44. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycaproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
45. Syu, W., W. Lee, B. Du, Q. Yu, M. Essex, and T. Lee. 1991. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J. Virol. 65:6349-6352.
46. Tersmette, M., R. E. de Goede, B. J. Al, I. N. Winkel, R A. Gruters, H. T. Cuypers, H. G. Hulsman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
47. Trujillo, J., W. Wang, T. Lee, and M. Essex. 1996. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. Virology 217:613-617.
48. Tschachler, E., H. Buchow, R. C. Gallo, and M. S. Reitz, Jr. 1990. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope. J. Virol. 64:2250-2259.
49. Tscherning, C., A. Alaeus, R. Fredriksson, A. Bjorndal, H. Deng, D. Littman, E. Fenyo, and J. Albert. 1998. Differences in chemokine receptor usage between genetic subtypes of HIV-1. Virology 241:181-188.
50. UNAIDS. 1996-1999. The global source of HIV/AIDS information. AIDS epidemic update. UNAIDS, Geneva, Switzerland.
51. Wang, W., T. Dudek, Y. Zhao, H. Brumblay, M. Essex, and T. Lee. 1998. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proc. Natl. Acad. Sci. USA 95:5740-5745.
52. Yu, X., X. Yuan, Z. Matsuda, T. H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:4966-4971.
53. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
54. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.